tiprankstipranks
Mitsubishi Research Institute (JP:3636)
:3636
Japanese Market
Want to see JP:3636 full AI Analyst Report?

Mitsubishi Research Institute (3636) AI Stock Analysis

1 Followers

Top Page

JP:3636

Mitsubishi Research Institute

(3636)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 5.2)
Rating:77Outperform
Price Target:
¥5,096.00
▲(4.86% Upside)
Action:ReiteratedDate:02/07/26
The score is driven primarily by strong financial performance (profitability and a very low-leverage balance sheet) and an attractive valuation (low P/E with a solid dividend). Technicals are supportive but less decisive due to mixed momentum signals, and declining free cash flow trends temper the otherwise solid fundamentals.
Positive Factors
Balance sheet strength
Minimal leverage (debt-to-equity 0.014) delivers durable financial flexibility and low interest burden. That conservatism supports multi-year contract performance, investment in capabilities and resilience through cyclical dips, preserving capacity for strategic spending.
Negative Factors
Free cash flow decline
A material drop in free cash flow growth and lower FCF-to-net-income indicate weaker cash conversion. That reduces the firm’s self-funding capacity for capex, platform investment or higher shareholder returns and raises sensitivity to working‑capital swings.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Minimal leverage (debt-to-equity 0.014) delivers durable financial flexibility and low interest burden. That conservatism supports multi-year contract performance, investment in capabilities and resilience through cyclical dips, preserving capacity for strategic spending.
Read all positive factors

Mitsubishi Research Institute (3636) vs. iShares MSCI Japan ETF (EWJ)

Mitsubishi Research Institute Business Overview & Revenue Model

Company Description
Mitsubishi Research Institute, Inc. provides think tank, consulting, and IT services to government agencies, financial institutions, and private companies in Japan. Its service solutions include management consulting, digital innovation, financial...
How the Company Makes Money
Mitsubishi Research Institute primarily makes money by delivering fee-based professional services and project work across two broad areas: (1) consulting/research and (2) IT solutions. On the consulting and research side, it earns revenue from com...

Mitsubishi Research Institute Financial Statement Overview

Summary
Strong overall fundamentals: revenue grew 4.05% with improved gross margin (24.91%) and solid profitability (net margin 5.26%). Balance sheet strength is a key positive with very low leverage (debt-to-equity 0.014), though ROE has softened. Main risk area is cash conversion, as free cash flow growth and FCF-to-net-income have declined despite healthy operating cash flow.
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
72
Positive
BreakdownSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Income Statement
Total Revenue121.46B115.36B122.13B116.62B103.03B
Gross Profit30.26B27.13B27.72B28.07B24.50B
EBITDA11.48B10.81B12.44B12.78B10.47B
Net Income6.39B5.00B6.29B7.71B5.01B
Balance Sheet
Total Assets131.00B121.90B120.27B116.44B101.57B
Cash, Cash Equivalents and Short-Term Investments30.31B30.93B25.23B33.16B29.40B
Total Debt1.04B1.11B2.09B3.53B4.93B
Total Liabilities49.65B45.52B45.88B45.28B37.73B
Stockholders Equity71.92B67.63B65.80B63.05B56.28B
Cash Flow
Free Cash Flow2.81B12.18B3.09B7.94B2.30B
Operating Cash Flow6.42B13.54B5.70B9.26B3.25B
Investing Cash Flow-4.00B-2.91B-2.41B-6.65B-1.97B
Financing Cash Flow-3.01B-4.94B-6.20B-3.85B-4.62B

Mitsubishi Research Institute Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4860.00
Price Trends
50DMA
4777.58
Positive
100DMA
4814.31
Positive
200DMA
4773.25
Positive
Market Momentum
MACD
43.14
Negative
RSI
57.27
Neutral
STOCH
53.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3636, the sentiment is Positive. The current price of 4860 is above the 20-day moving average (MA) of 4748.34, above the 50-day MA of 4777.58, and above the 200-day MA of 4773.25, indicating a bullish trend. The MACD of 43.14 indicates Negative momentum. The RSI at 57.27 is Neutral, neither overbought nor oversold. The STOCH value of 53.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3636.

Mitsubishi Research Institute Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
¥71.09B3.153.28%12.54%171.52%
76
Outperform
¥154.38B14.812.30%15.87%40.46%
75
Outperform
¥144.08B9.3411.52%2.76%4.91%48.93%
66
Neutral
¥162.13B15.9918.89%2.78%9.16%59.49%
65
Neutral
¥30.24B10.7510.34%4.82%-2.83%5.48%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3636
Mitsubishi Research Institute
4,490.00
205.56
4.80%
JP:9682
DTS
1,020.00
-86.82
-7.84%
JP:9715
transcosmos
3,845.00
746.54
24.09%
JP:4725
CAC Holdings Corporation
1,791.00
-172.46
-8.78%
JP:2317
Systena Corporation
426.00
68.25
19.08%

Mitsubishi Research Institute Corporate Events

Mitsubishi Research Institute Posts Strong First-Half Profit Surge and Confirms Dividend Outlook
Apr 27, 2026
Mitsubishi Research Institute reported consolidated net sales of ¥72.6 billion for the six months ended March 31, 2026, up 10.9% year on year, with operating profit surging 36.3% to ¥9.3 billion and profit attributable to owners of paren...
Mitsubishi Research Institute Posts Profit Surge but Keeps Cautious Full-Year Outlook
Feb 5, 2026
Mitsubishi Research Institute reported a strong rebound in earnings for the quarter ended December 31, 2025, with net sales rising 11.5% year on year to ¥30.9 billion and profit attributable to owners of parent surging 165.6% to ¥2.63 bi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 07, 2026